Status:
NOT_YET_RECRUITING
Accuracy Assessment of a Novel Gas Detection Approach in Dyslipidemia Diagnosis
Lead Sponsor:
Beijing Anzhen Hospital
Conditions:
Dyslipidemias
Gas Detection Method
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to validate the feasibility and accuracy of a novel gas detection method for dyslipidemia screening by analyzing the lipid profile of human breath metabolites. It explores a simple, ra...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Voluntarily signed the informed consent form
Exclusion
- Patients with lung cancer, asthma, chronic obstructive pulmonary disease, pulmonary cystic fibrosis, or acute respiratory distress syndrome
- Women who are pregnant or breastfeeding
- Patients with chronic kidney disease (GFR \< 60 ml/min) or cirrhosis
- Individuals unable to cooperate with the collection of exhaled gas samples
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06486857
Start Date
July 1 2024
End Date
December 30 2026
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen hospital
Beijing, Beijing Municipality, China, 100029